MUCOSAL MELANOMA
Clinical trials for MUCOSAL MELANOMA explained in plain language.
Never miss a new study
Get alerted when new MUCOSAL MELANOMA trials appear
Sign up with your email to follow new studies for MUCOSAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to extend life for advanced melanoma patients
Disease control OngoingThis study is testing an experimental drug called dinaciclib in people with stage IV melanoma that has spread. The main goal is to see if the treatment helps patients live at least one year longer. Researchers will also monitor how well it controls the cancer's growth and what si…
Matched conditions: MUCOSAL MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New strategy: shrink tumors before surgery to fight advanced melanoma
Disease control OngoingThis study is comparing two different timing strategies for an immunotherapy drug called pembrolizumab in patients with high-risk melanoma that can be surgically removed. It aims to see if giving the drug *before* surgery (to shrink the tumor) works better than the standard appro…
Matched conditions: MUCOSAL MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Can your diet boost cancer treatment? new study investigates
Disease control OngoingThis study is testing whether eating a high-fiber diet can improve gut health and help the immune system fight cancer in patients with advanced melanoma who are receiving standard immunotherapy. Fifty participants will be randomly assigned to follow either a high-fiber diet or a …
Matched conditions: MUCOSAL MELANOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
First human test: using Patients' own immune cells to fight advanced skin cancer
Disease control OngoingThis early-stage study is testing a personalized treatment called TBio-4101 for people with advanced melanoma that hasn't responded to standard therapies. Doctors take immune cells from a patient's tumor, grow them in large numbers in a lab, and then infuse them back into the pat…
Matched conditions: MUCOSAL MELANOMA
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC